New Grants to Boost Preeclampsia Research
The Preeclampsia Foundation has unveiled the recipients of its latest research grant program aimed at enhancing the understanding and treatment of preeclampsia. This initiative is made possible by significant funding dedicated to groundbreaking research that could lead to innovative therapies for this serious pregnancy complication.
Grants Awarded to Leading Researchers
Two notable researchers, Dr. Zsuzsanna K. Zsengellér and Virginia D. Winn, MD, PhD, have each received grants totaling $99,997. These grants are part of the Peter Joseph Pappas Research Grant program which focuses on pivotal studies that can aid in the development of targeted therapeutic approaches for preeclampsia.
Dr. Zsuzsanna K. Zsengellér's Research Focus
Dr. Zsengellér, associated with the Beth Israel Deaconess Medical Center and Harvard Medical School, is pursuing her project titled "Novel small molecule therapeutics for the treatment of preeclampsia." This research aims to tackle oxidative stress—an influential factor in the onset of preeclampsia—through the use of hydrazone-based antioxidants. Her work is a collaborative effort with the Török Lab at the University of Massachusetts Boston.
Virginia D. Winn's Innovative Approach
On the other hand, Dr. Virginia D. Winn, a prominent figure in maternal-fetal medicine at Stanford University, is leading a project entitled "Harnessing Paired Maternal-Child iPSCs to Model PE." This project utilizes induced pluripotent stem cells from mother-child pairs to investigate the complexities of preeclampsia and its various subtypes, significantly contributing to the current understanding of this condition.
Honoring the Legacy of Peter Joseph Pappas
The grants are named in memory of Peter Joseph, son of Lauren and Clement Pappas, who tragically passed away due to complications from preeclampsia. After experiencing the loss of their child, the Pappas family dedicated themselves to fostering research that aims to prevent such outcomes for others. Their commitment has led to this program, which awards up to $200,000 annually to research initiatives that can change the future of maternal health.
Community Support and Future Goals
The Pappas family's efforts are supported by numerous contributions from generous individuals, which strengthen the mission to eliminate pre-term births caused by severe preeclampsia and related complications by 2050. "Our partnership with the Preeclampsia Foundation is crucial in reaching our ultimate goal of enhancing maternal and child health," noted Clement Pappas.
Preeclampsia Foundation’s Research Initiatives
The Peter Joseph Pappas Research Grant program complements various research initiatives spearheaded by the Preeclampsia Foundation. Other programs include the Vision Grant for young researchers, PRIME focusing on health services research, and EMPOWER, which enhances research capabilities in low- and middle-income countries.
About the Preeclampsia Foundation
The Preeclampsia Foundation, established in 2000, is a non-profit organization dedicated to improving outcomes for families affected by hypertensive disorders during pregnancy. Its mission encompasses community education, healthcare improvements, and the pursuit of effective treatments for preeclampsia and similar conditions. The foundation envisions a future where these disorders no longer jeopardize the lives of mothers and infants.
Contact Information for Inquiries
For any queries related to the Peter Joseph Pappas Research Grants program, please reach out to their Director of Communications and Engagement, Laney Poye, at 321.421.6957. Through shared commitment and groundbreaking research, the Preeclampsia Foundation aims to foster a healthier future for mothers and their children.
Frequently Asked Questions
What is the Preeclampsia Foundation?
The Preeclampsia Foundation is a nonprofit organization focused on improving maternal and child health outcomes regarding hypertensive disorders in pregnancy.
What are the Peter Joseph Pappas Research Grants?
These grants fund innovative research projects aimed at understanding and treating preeclampsia, helping to prevent complications during pregnancy.
Who are the recipients of the grants this year?
Dr. Zsuzsanna K. Zsengellér and Virginia D. Winn, MD, PhD, are this year's recipients, each receiving significant funding for their respective research projects.
What is Dr. Zsengellér's research about?
Her research focuses on developing new antioxidant therapies to mitigate oxidative stress related to preeclampsia.
How can individuals donate to the Preeclampsia Foundation?
Donations can be made directly through the Preeclampsia Foundation’s website, supporting research and awareness about hypertensive disorders of pregnancy.
